ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
-4.52%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$206M
AUM Growth
-$145M
Cap. Flow
-$76.7M
Cap. Flow %
-37.17%
Top 10 Hldgs %
61.73%
Holding
45
New
9
Increased
7
Reduced
14
Closed
12

Top Buys

1
VSTM icon
Verastem
VSTM
+$9.5M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$8.22M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$7.04M
4
GYRE icon
Gyre Therapeutics
GYRE
+$6.05M
5
LSACU
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
+$5.6M

Top Sells

1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$20.1M
2
AXSM icon
Axsome Therapeutics
AXSM
+$17.6M
3
KDMN
Kadmon Holdings, Inc.
KDMN
+$15.4M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$11.3M
5
ARWR icon
Arrowhead Research
ARWR
+$9.57M

Sector Composition

1 Healthcare 93.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNS
26
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.11M 1.02%
+259,500
New +$2.11M
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.99M 0.97%
+39,000
New +$1.99M
KURA icon
28
Kura Oncology
KURA
$729M
$1.97M 0.95%
198,000
-42,000
-18% -$418K
LRMR icon
29
Larimar Therapeutics
LRMR
$363M
$1.07M 0.52%
115,500
+32,167
+39% +$297K
BCRX icon
30
BioCryst Pharmaceuticals
BCRX
$1.7B
$500K 0.24%
250,000
-2,575,000
-91% -$5.15M
ISEE
31
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$478K 0.23%
139,000
-771,000
-85% -$2.65M
ABUS icon
32
Arbutus Biopharma
ABUS
$957M
$273K 0.13%
+269,907
New +$273K
KPTI icon
33
Karyopharm Therapeutics
KPTI
$55M
– –
-39,333
Closed -$11.3M
INSM icon
34
Insmed
INSM
$31B
– –
-169,000
Closed -$4.04M
KALV icon
35
KalVista Pharmaceuticals
KALV
$739M
– –
-107,500
Closed -$1.92M
MIST icon
36
Milestone Pharmaceuticals
MIST
$158M
– –
-508,500
Closed -$8.14M
NGNE icon
37
Neurogene
NGNE
$275M
– –
-18,625
Closed -$4.59M
XBI icon
38
SPDR S&P Biotech ETF
XBI
$5.49B
– –
0
– –
XFOR icon
39
X4 Pharmaceuticals
XFOR
$71.6M
– –
-1,333
Closed -$428K
ZYME icon
40
Zymeworks
ZYME
$1.2B
– –
-70,500
Closed -$3.21M
GRCE
41
Grace Therapeutics, Inc. Common Stock
GRCE
$45.5M
– –
-12,917
Closed -$1.52M
ITCI
42
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-587,089
Closed -$20.1M
CCXI
43
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-35,000
Closed -$1.38M
IMMU
44
DELISTED
Immunomedics Inc
IMMU
– –
-150,000
Closed -$3.17M
MDCO
45
DELISTED
Medicines Co
MDCO
– –
-21,700
Closed -$1.84M
1
2